Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Coronavirus Notebook: Moderna Claims 94.5% Vaccine Efficacy, Janssen Starts Second ENSEMBLE Trial
Nov 16 2020
•
By
Ian Schofield
Moderna's COVID-19 vaccine is now under rolling review in the EU • Source: Shutterstock
More from Europe
More from Geography